Nursing Department, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Centre of Neurological and Metabolic Research, the Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Front Endocrinol (Lausanne). 2024 Jan 3;14:1284160. doi: 10.3389/fendo.2023.1284160. eCollection 2023.
Gestational diabetes mellitus is a prevalent metabolic disease that can impact the normal course of pregnancy and delivery, leading to adverse outcomes for both mother and child. Its pathogenesis is complex and involves various factors, such as insulin resistance and β-cell dysfunction. Metabolic reprogramming, which involves mitochondrial oxidative phosphorylation and glycolysis, is crucial for maintaining human metabolic balance and is involved in the pathogenesis and progression of gestational diabetes mellitus. However, research on the link and metabolic pathways between metabolic reprogramming and gestational diabetes mellitus is limited. Therefore, we reviewed the relationship between metabolic reprogramming and gestational diabetes mellitus to provide new therapeutic strategies for maternal health during pregnancy and reduce the risk of developing gestational diabetes mellitus.
妊娠期糖尿病是一种常见的代谢性疾病,可影响妊娠和分娩的正常过程,导致母婴不良结局。其发病机制复杂,涉及胰岛素抵抗和β细胞功能障碍等多种因素。代谢重编程涉及线粒体氧化磷酸化和糖酵解,对于维持人体代谢平衡至关重要,并且参与了妊娠期糖尿病的发病机制和进展。然而,代谢重编程与妊娠期糖尿病之间的关联和代谢途径的研究有限。因此,我们综述了代谢重编程与妊娠期糖尿病之间的关系,为妊娠期母婴健康提供新的治疗策略,并降低妊娠期糖尿病的发病风险。